신경병증성 통증 시장 규모, 점유율, 성장 분석 : 제품 유형별, 시술별, 기술별, 모달리티별, 구입 형태별, 지역별 - 산업 예측(2025-2032년)
Neuropathic Pain Market Size, Share, and Growth Analysis, By Type, By Product Type, By Procedure, By Technology, By Modality, By Mode of Purchase, By Region - Industry Forecast 2025-2032
상품코드:1687496
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
신경병증성 통증 시장 규모는 2023년에 26억 9,000만 달러로 평가되며, 2024년 28억 3,000만 달러에서 2032년에는 42억 8,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.3%로 성장할 전망입니다.
당뇨병과 같은 만성질환의 유병률 증가와 고령화는 신경병증성 통증의 유병률 증가의 주요 요인입니다. 이러한 추세는 혁신적인 치료법 및 의약품 솔루션의 발견을 목표로 하는 중요한 연구개발 활동을 촉진하여 시장 성장을 가속하고 있습니다. 또한 신경병증성 통증의 효과적인 관리에 대한 의료 전문가와 환자들의 인식이 높아짐에 따라 시장 확대가 더욱 촉진되고 있습니다. 제약회사들이 미충족 의료 수요를 충족시키기 위해 지속적으로 새로운 약물과 치료법을 출시함에 따라 시장은 활기를 띠고 있으며, 이는 기술 혁신과 진화하는 치료 전략의 역동적인 상황을 강조하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
신경병증성 통증 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
척수 자극(SCS) 기기
외부 말초신경 자극
경피적 전기 신경 자극(TENS) 기기
국소 신경장애
자동 신경장애
근위신경장애
신경병증성 통증 시장 규모 : 제품 유형별 & CAGR(2025-2032)
시장 개요
충전식
비충전식
신경병증성 통증 시장 규모 : 시술별 & CAGR(2025-2032)
시장 개요
침습적
비침습적
신경병증성 통증 시장 규모 : 기술별 & CAGR(2025-2032)
시장 개요
경피적 전기 신경 자극
경두개 자기 자극
호흡 전기 자극
신경병증성 통증 시장 규모 : 모달리티별 & CAGR(2025-2032)
시장 개요
고정형
휴대용
신경병증성 통증 시장 규모 : 구입 형태별 & CAGR(2025-2032)
시장 개요
OTC(Over-the-Counter) 기기
처방전 기반 기기
신경병증성 통증 시장 규모 : 통증의 유형별 & CAGR(2025-2032)
시장 개요
말초신경병증
교액성 신경장애(Entrapment Neuropathy)
환지 신경증
삼차 신경통
대상포진 후 신경통(PHN)
외상 후 신경장애
발 통증
미골통
신경병증성 통증 시장 규모 : 적응증별 & CAGR(2025-2032)
시장 개요
척주관협착증
화학요법 유발성 말초신경병증
당뇨병성 신경장애
기타
신경병증성 통증 시장 규모 : 진단별 & CAGR(2025-2032)
시장 개요
영상 진단
혈액검사
신체검사
신경병증성 통증 시장 규모 : 치료별 & CAGR(2025-2032)
시장 개요
의약품
멀티모달 테라피
신경병증성 통증 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원
클리닉
재택 헬스케어
외래 수술 센터
조사 조직
기타
신경병증성 통증 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
직접 입찰
서드파티 유통업체
기타
신경병증성 통증 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(USA)
Novartis AG(Switzerland)
Eli Lilly and Company(USA)
Johnson & Johnson(USA)
GlaxoSmithKline plc(UK)
Teva Pharmaceutical Industries Ltd.(Israel)
Astellas Pharma Inc.(Japan)
Abbott Laboratories(USA)
Medtronic plc(Ireland)
Boston Scientific Corporation(USA)
Biogen Inc.(USA)
Merck & Co., Inc.(USA)
Bristol Myers Squibb(USA)
AbbVie Inc.(USA)
Grunenthal GmbH(Germany)
AstraZeneca PLC(UK)
Daiichi Sankyo Company, Limited(Japan)
결론과 제안
KSA
영문 목차
영문목차
Neuropathic Pain Market size was valued at USD 2.69 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.28 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).
The rising prevalence of chronic conditions like diabetes and an ageing population are key factors contributing to the increasing incidence of neuropathic pain. This trend is fostering significant research and development activities aimed at discovering innovative therapies and pharmaceutical solutions, which are propelling market growth. Moreover, heightened awareness among healthcare professionals and patients regarding effective neuropathic pain management further fuels this expansion. The market remains vibrant as pharmaceutical companies persistently launch new medications and treatment options to meet the unmet medical needs associated with neuropathic pain, highlighting a dynamic landscape of innovation and evolving therapeutic strategies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Neuropathic Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Neuropathic Pain Market Segments Analysis
Global Neuropathic Pain Market is segmented by Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel and region. Based on Type, the market is segmented into Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Focal Neuropathy, Automatic Neuropathy and Proximal Neuropathy. Based on Product Type, the market is segmented into Rechargeable and Non-Rechargeable. Based on Procedure, the market is segmented into Invasive and Non-Invasive. Based on Technology, the market is segmented into Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation. Based on Modality, the market is segmented into Stationary and Portable. Based on Mode of Purchase, the market is segmented into Over-the-Counter Devices and Prescription-Based Devices. Based on Pain Type, the market is segmented into Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain and Coccydynia. Based on Indication, the market is segmented into Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy and Others. Based on Diagnosis, the market is segmented into Imaging, Blood Tests and Physical Examination. Based on Treatment, the market is segmented into Medications and Multimodal Therapy. Based on End User, the market is segmented into Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Research Organization and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Third Party Distributor and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Neuropathic Pain Market
The neuropathic pain market is significantly driven by the rising prevalence of chronic illnesses, including diabetes, various types of cancer, and neurological disorders, which has resulted in a greater incidence of neuropathic pain cases worldwide. As the global population ages, the associated risk factors for neuropathic pain are also increasing, further boosting market demand. Additionally, continuous advancements in research and pharmaceutical innovation are leading to the development of new medications and therapies specifically targeting neuropathic pain, thereby improving treatment options. Together, these factors are creating a robust environment for growth in the neuropathic pain market.
Restraints in the Neuropathic Pain Market
A significant constraint in the neuropathic pain market arises from the challenges linked to accurate diagnosis and the inherently subjective nature of pain assessment, which can hinder effective identification and measurement of neuropathic pain. This often results in underreporting or improper management of the condition. Additionally, the high costs associated with sophisticated treatment options and medications may further limit access to these therapies, particularly in regions with constrained healthcare budgets. These factors collectively hinder the growth of the market, affecting both patient outcomes and overall market dynamics in the management of neuropathic pain.
Market Trends of the Neuropathic Pain Market
The neuropathic pain market is witnessing a significant trend towards the development of innovative treatment modalities, driven by a robust focus on research and pharmaceutical advancements. This evolving landscape is catalyzed by the increasing recognition of neuropathic pain's complexities, prompting the exploration of tailored therapeutic solutions. Furthermore, the rise of telehealth and virtual healthcare platforms is transforming the diagnosis, monitoring, and management of neuropathic pain, making care more accessible and personalized. These advancements not only enhance patient engagement but also allow for real-time adjustments to treatment plans, ultimately improving outcomes and driving market growth in this dynamic sector.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Neuropathic Pain Market Size by Type & CAGR (2025-2032)
Global Neuropathic Pain Market Size by Product Type & CAGR (2025-2032)
Market Overview
Rechargeable
Non-Rechargeable
Global Neuropathic Pain Market Size by Procedure & CAGR (2025-2032)
Market Overview
Invasive
Non-Invasive
Global Neuropathic Pain Market Size by Technology & CAGR (2025-2032)
Market Overview
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Global Neuropathic Pain Market Size by Modality & CAGR (2025-2032)
Market Overview
Stationary
Portable
Global Neuropathic Pain Market Size by Mode of Purchase & CAGR (2025-2032)
Market Overview
Over-the-Counter Devices
Prescription-Based Devices
Global Neuropathic Pain Market Size by Pain Type & CAGR (2025-2032)
Market Overview
Peripheral Neuropathy
Entrapment Neuropathy
Phantom Limb Neuropathy
Trigeminal Neuralgia
Post Herpetic Neuralgia (PHN)
Post Traumatic Neuropathy
Foot Pain
Coccydynia
Global Neuropathic Pain Market Size by Indication & CAGR (2025-2032)
Market Overview
Spinal Stenosis
Chemotherapy-Induced Peripheral Neuropathy
Diabetic Neuropathy
Others
Global Neuropathic Pain Market Size by Diagnosis & CAGR (2025-2032)
Market Overview
Imaging
Blood Tests
Physical Examination
Global Neuropathic Pain Market Size by Treatment & CAGR (2025-2032)
Market Overview
Medications
Multimodal Therapy
Global Neuropathic Pain Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Clinics
Home Healthcare
Ambulatory Surgical Centers
Research Organization
Others
Global Neuropathic Pain Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Direct Tender
Third Party Distributor
Others
Global Neuropathic Pain Market Size & CAGR (2025-2032)
North America (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
US
Canada
Europe (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
